MoonLake Immunotherapeutics (NASDAQ MLTX) Revenue and Competitors
Estimated Revenue & Valuation
- MoonLake Immunotherapeutics (NASDAQ MLTX)'s estimated annual revenue is currently $25.6M per year.
- MoonLake Immunotherapeutics (NASDAQ MLTX)'s estimated revenue per employee is $189,444
Employee Data
- MoonLake Immunotherapeutics (NASDAQ MLTX) has 135 Employees.
- MoonLake Immunotherapeutics (NASDAQ MLTX) grew their employee count by 75% last year.
MoonLake Immunotherapeutics (NASDAQ MLTX)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Director Project Management | Reveal Email/Phone |
MoonLake Immunotherapeutics (NASDAQ MLTX) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11M | 71 | 13% | N/A | N/A |
#2 | $38.8M | 250 | 22% | N/A | N/A |
#3 | $2M | 13 | 8% | N/A | N/A |
#4 | $4.3M | 28 | 300% | N/A | N/A |
#5 | $0.9M | 6 | 50% | N/A | N/A |
#6 | $1.7M | 11 | -31% | N/A | N/A |
#7 | $19.7M | 127 | 28% | N/A | N/A |
#8 | $9.3M | 60 | 25% | $40.2M | N/A |
#9 | $37.4M | 623 | -2% | $250.2M | N/A |
#10 | $4.8M | 31 | -22% | N/A | N/A |
What Is MoonLake Immunotherapeutics (NASDAQ MLTX)?
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
keywords:N/A
N/A
Total Funding
135
Number of Employees
$25.6M
Revenue (est)
75%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Zug
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20M | 138 | 28% | N/A |
#2 | $20.2M | 139 | 17% | N/A |
#3 | $19.7M | 141 | 8% | N/A |
#4 | $23M | 144 | 31% | N/A |
#5 | $10.5M | 145 | 24% | N/A |